Teewinot Capital Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$158M Buy
131,992
+17,381
+15% +$17.8M 11.45% 1
2026
Q1
$105M Sell
114,611
-27,500
-19% -$27.9M 8.41% 2
2025
Q4
$153M Sell
142,111
-13,398
-9% -$12.8M 11.21% 1
2025
Q3
$119M Buy
155,509
+65,108
+72% +$48.5M 9.22% 2
2025
Q2
$70.5M Buy
90,401
+17,581
+24% +$13.7M 5.79% 9
2025
Q1
$60.1M Sell
72,820
-25,237
-26% -$21M 6.15% 6
2024
Q4
$75.7M Buy
98,057
+12,138
+14% +$10.1M 7.72% 3
2024
Q3
$76.1M Sell
85,919
-1,139
-1% -$1.02M 7.69% 5
2024
Q2
$78.8M Sell
87,058
-1,048
-1% -$838K 7.77% 5
2024
Q1
$68.5M Buy
88,106
+31,269
+55% +$22.3M 7.18% 4
2023
Q4
$33.1M Sell
56,837
-59,472
-51% -$34.7M 5.01% 8
2023
Q3
$62.5M Buy
116,309
+30,749
+36% +$15.8M 9.98% 1
2023
Q2
$40.1M Buy
85,560
+17,416
+26% +$7.3M 6.79% 6
2023
Q1
$23.4M Buy
68,144
+19,492
+40% +$6.57M 4.63% 6
2022
Q4
$17.8M Sell
48,652
-20,370
-30% -$7.22M 3.98% 12
2022
Q3
$22.3M Buy
+69,022
New +$21.9M 5.11% 10

Other funds holding LLY

Teewinot Capital Advisers's LLY Position: Q2 2026 in Review

Teewinot Capital Advisers increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $17.8M and bringing the position to 131,992 shares worth $158M. The position accounts for 11.45% of the portfolio, ranked #1.

Teewinot Capital Advisers first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Teewinot Capital Advisers held 131,992 shares of Eli Lilly worth $158M as of Q2 2026.
  • Teewinot Capital Advisers bought 17,381 Eli Lilly shares in Q2 2026, an estimated $17.8M.
  • Eli Lilly made up 11.45% of Teewinot Capital Advisers's portfolio in Q2 2026, its #1 holding.
  • Teewinot Capital Advisers first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Teewinot Capital Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.